| Accession Number | 0001193125-26-402815 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 25, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Sep 24, 2026 | Exercise/Conversion | 30,000 | $6.15 | $184,500.00 | 63,053 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Sep 24, 2026 | Sale | 20,726 | $10.83 | $224,514.39 | 42,327 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Sep 24, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |